Predicting the Severity of Lockdown-Induced Psychiatric Symptoms with Machine Learning.
Giordano D'UrsoAlfonso MagliacanoSayna RotbeiFelice IasevoliAndrea de BartolomeisAlessio BottaPublished in: Diagnostics (Basel, Switzerland) (2022)
During the COVID-19 pandemic, an increase in the incidence of psychiatric disorders in the general population and an increase in the severity of symptoms in psychiatric patients have been reported. Anxiety and depression symptoms are the most commonly observed during large-scale dramatic events such as pandemics and wars, especially when these implicate an extended lockdown. The early detection of higher risk clinical and non-clinical individuals would help prevent the new onset and/or deterioration of these symptoms. This in turn would lead to the implementation of public policies aimed at protecting vulnerable populations during these dramatic contingencies, therefore optimising the effectiveness of interventions and saving the resources of national healthcare systems. We used a supervised machine learning method to identify the predictors of the severity of psychiatric symptoms during the Italian lockdown due to the COVID-19 pandemic. Via a case study, we applied this methodology to a small sample of healthy individuals, obsessive-compulsive disorder patients, and adjustment disorder patients. Our preliminary results show that our models were able to predict depression, anxiety, and obsessive-compulsive symptoms during the lockdown with up to 92% accuracy based on demographic and clinical characteristics collected before the pandemic. The presented methodology may be used to predict the psychiatric prognosis of individuals under a large-scale lockdown and thus supporting the related clinical decisions.
Keyphrases
- machine learning
- healthcare
- end stage renal disease
- obsessive compulsive disorder
- sleep quality
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- systematic review
- prognostic factors
- sars cov
- emergency department
- artificial intelligence
- randomized controlled trial
- quality improvement
- big data
- coronavirus disease
- oxidative stress
- living cells
- social media
- health information
- sensitive detection
- health insurance
- diabetic rats
- breast cancer risk